In addition to having the melanoma panel, the additional reportable prostate gene panel could include BRCA1, BRCA2, CHEK2, HOXB13, MLH1, MSH2, MSH6, NBN, PMS2, and TP53. Preliminary evidence genes include ATM (Fig. 2). This evidence concerns the gene BRCA1 and melanoma.